According to the latest figures, the current death rate from cancer is 7.6 million people per year, with an additional 12.4 million people annually developing various types of the disease. These alarming figures are set to double by 2030. Better patient care and the search for a cure are of major concern for cancer patients and their families, the medical community, national health systems, the pharmaceutical industry, and society as a whole.
Medical images play an increasingly important role in diagnosing and treating cancer patients. In the clinical setting, imaging data enable physicians to better evaluate whether a cancer patient is responding to therapy and to adjust the therapy accordingly. At the research level, medical images are instrumental in the development and the evaluation of new cancer drugs and innovative therapeutic approaches.
MEDIAN Technologies provides advanced medical imaging products and integrated services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development.
Our goal is to transform image interpretation from an objective art to a quantitative science to facilitate better, more reliable outcomes for cancer patients.